Polycystic ovary syndrome (PCOS) is the most common endocrine disease among premenopausal women. The genetic risk of PCOS in the Saudi population is still unclear. Therefore, it is of interest to study the genotype and allele frequency for six gene variants (THADA rs13429458, TOX3 rs4784165, FSHRrs2268361, YAP1 rs1894116, RAB5B rs705702, and HMGA2 rs2272046) in patients with PCOS in western Saudi population. The study included 95 PCOS patients and 94 normal ovulatory females as controls. Genotyping was performed using TaqMan TM real-time polymerase chain reaction assays. There was significant link between the THADA rs13429458 variant and PCOS. Homozygosity in allele A of the rs13429458 variant was correlated with hyperandrogenism (HA) risk. Homozygosity in the T allele of the FSHR rs2268361 variant was associated with normal levels of AMH among non-PCOS women. The THADA rs13429458 and TOX3 rs4784165 variants were significantly associated with the combined oligo/amenorrhea (OA) and polycystic ovarian morphology subgroups while the HMGA2 rs2272046 variant was significantly associated with the combined HA and OA subgroup. Thus, results show the genetic risk of the THADA rs13429458, TOX3 rs4784165, and HMGA2 rs2272046 variants on PCOS patients in the western Saudi population.
Background:
The diagnostic criteria for polycystic ovary syndrome (PCOS), a complex endocrine disorder affecting reproductive-aged women, have evolved since the disorder was first recognized. The National Institutes of Health first defined PCOS as the presence of clinical or biochemical hyperandrogenism (HA) comorbid with oligo/amenorrhea (OA) [1] . The Rotterdam consensus added the polycystic ovarian morphology (PCOM) phenotype, and the diagnosis was redefined as the presence of two out of the three conditions [2] . The Androgen Excess Society subsequently considered HA a key component in PCOS diagnosis [3] . The Rotterdam criteria was endorsed by an Endocrine Society clinical practice guideline [4] . According to the diagnostic criteria, the prevalence of PCOS varies worldwide but is generally 6-20% [5] [6] [7] . Although there are no prevalence studies that include the entire kingdom of Saudi Arabia, a study conducted in the city of Madinah found a prevalence of 32.5% [8] . Associated with significant multiple clinical manifestations including reproductive, metabolic, and psychological disorders [9-15], PCOS represents 80% of anovulatory infertility cases [10] , and 80-85% of women with clinical HA have PCOS [16, 17] . Manifestation of the disorder varies depending upon the particular diagnostic criteria. Patients diagnosed according to the Rotterdam and NIH criteria are at higher risk of developing reproductive and metabolic disorders such as infertility and type-2 diabetes [18 -21] . The etiology of PCOS is not entirely clear; however, the disease is primarily attributed to multiple genetic and environmental factors aggravated by obesity [22] .
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©Biomedical Informatics (2019) The THADA gene encodes the thyroid adenoma-associated protein, expressed in the pancreas, adrenal medulla, thyroid, adrenal cortex, testis, thymus, small intestine, and stomach [33] . It was first identified as a target of 2p21 chromosomal aberrations in benign thyroid adenomas, where it disrupted and fused to an intron of peroxisome proliferator-activated receptor gamma (PPARγ) , and written informed consent was obtained from participants prior to sample collection. The study was conducted in accordance with the Declaration of Helsinki. The PCOS patients were divided into four subgroups according to their clinical symptoms. Each subgroup was tested individually to investigate whether the associations between SNPs and PCOS were absolute or relative to combined symptoms. After classification of the patients into subgroups, the sample size was 82 as 13 patients were excluded to avoid misleading results as the third symptom (HA) was not investigated (Table 1 ). 
Statistical analysis:
Data analysis was conducted using the IBM SPSS software version 24 (SPSS TM Inc., NY, USA). The participants clinical characteristics were expressed as median ± inter quartile range (IQR), and p-values were calculated using the Mann-Whitney test as the data were nonnormally distributed. The genotype and allele data were expressed as frequencies. The differences between study groups were analyzed using the chi-squared test. Multinomial logistic regression was used to examine the association of the variants with PCOS clinical variables. Values of p < 0.05 were considered statistically significant.
Results:
All participant clinical parameters are listed in Table 2 .
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©Biomedical Informatics (2019) There was a significant link between AMH at the previously determined [45] cutoff level (3.19 ng/ml) and FSHR variant rs2268361 in the control group (p = 0.016, Table 5 ). Multinomial logistic regression showed a significant association between the TT genotype of the rs2268361 variant and normal levels of AMH (<3.19) (OR = 6.2, B = 1.821, p = 0.009). Hence, homozygosity in the T allele of rs2268361 is potentially protective, associated with normal levels of AMH among non-PCOS women. No relationship was detected between the other clinical parameters including obesity, OA, and PCOM, and the six SNPs using the chi-squared test.
Allele and genotype frequency:
The genotype distribution and allele frequencies of the six SNPs are listed in Table 3 . There was significant relationship between PCOS and THADA rs13429458 (p = 0.033), but no link was detected with the other genetic variants.
The association of the six variants with PCOS clinical characteristics
There was a significant relationship between THADA variant rs13429458 and HA phenotype in the PCOS group (p = 0.031, Table  4 ) by the chi-squared test. Multinomial logistic regression revealed that the AA genotype in THADA variant rs13429458 was positively correlated with higher frequency of HA than the AC genotype (OR = 2.9, B = 1.053, p = 0.026). Therefore, homozygosity in allele A in rs13429458 variant is predicted as a risk genotype associated with HA. THADArs13429458 and TOX3rs4784165 variants are correlated to the OA+PCOM subgroup The PCOS group was divided into four subgroups according to the clinical symptoms. There was significant correlation between the THADA rs13429458 and TOX3 rs4784165 SNPs and the OA+PCOM subgroup (p = 0.009, p = 0.028 respectively, Table 6 ).
HMGA2rs2272046 variant is correlated to HA+OA subgroup
The HMGA2variant rs2272046 showed a significant correlation with the HA+OA subgroup (p = 0.043, Table 6 ). No other correlations were detected among other variants within PCOS subgroups.
Discussion
In the last two decades, numerous studies have focused on the genetic pathogenesis of PCOS in order to understand the genetic predisposition to the disorder. In the present study, we examined six previously reported PCOS-associated SNPs identified collectively through GWAS in populations of Chinese It was demonstrated that the AMH receptors expressed in the brain may be involved in initiation of gonadotropin-releasing hormone (GnRH) release from hypothalamic neurons [52] . GnRH causes the pituitary gland in the brain to make and secrete FSH [53] which may explain our finding correlation of the FSHR rs2268361 variant and AMH at cutoff level in the control group. Furthermore, FSH, as well as AMH, contributes to follicle development, and AMH preserves the follicles in the primordial stage, estimates the number of ovum in the ovaries, thereby indicating the ovary reserve [54, 55] . In PCOS,FSH-the principal regulator of follicular growth and maturation [56]-is suppressed below the level needed in the early follicular phase to stimulate normal follicle maturation. As a result, the development of large antral follicles (5-8 mm) is arrested [57]. The arrested antral follicles will increase serum AMH in PCOS women due to greater production of AMH per follicle [58, 59].
The PCOS subgroups differed significantly on almost all anthropometric, endocrine, and metabolic characteristics [60] . Thus, we analyzed the association of each subgroup separately with the SNPs to determine the variations with different clinical variables. Accordingly, we detected significant correlation of THADA rs13429458 variant, TOX3 rs4784165variant with the OA+PCOM subgroup, and HMGA2 rs2272046variant with the HA+PCOM subgroup. TOX3 and HMGA2 genes are well-known contributors to PCOS through enhancement of the activity of transcription factors such as the estrogen receptor [36] and promoting the proliferation of granulosa cells [38], respectively. No significant association of PCOS or its phenotypes with FSHR rs2268361, YAP1rs1894116, or RAB5B rs705702 in the Saudi population, which could be attributed to the small sample size.
